NASDAQ:EMBC - Embecta Stock Price Target and Predictions

  • Consensus Rating: Sell
  • Consensus Price Target: $25.00
  • Forecasted Upside: -4.62 %
  • Number of Analysts: 1
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$26.21
▲ +0.13 (0.50%)

This chart shows the closing price for EMBC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Embecta Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EMBC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EMBC

Analyst Price Target is $25.00
▼ -4.62% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Embecta in the last 3 months. The average price target is $25.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a -4.62% upside from the last price of $26.21.

This chart shows the closing price for EMBC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Sell

The current consensus among 1 contributing investment analysts is to sell stock in Embecta.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/10/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/10/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/9/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/7/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/5/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/5/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/4/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
7/4/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/21/2022Bank of AmericaInitiated CoverageUnderperform$25.00Low
(Data available from 7/5/2017 forward)

News Sentiment Rating

0.16 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/7/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/6/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/5/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/7/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/6/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/6/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/5/2022
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/5/2022

Current Sentiment

  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

Embecta logo
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
Read More

Today's Range

Now: $26.21
Low: $24.59
High: $26.26

50 Day Range

MA: $27.80
Low: $24.78
High: $32.44

52 Week Range

Now: $26.21
Low: $23.84
High: $49.00

Volume

593,073 shs

Average Volume

1,499,293 shs

Market Capitalization

$1.51 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Embecta?

The following equities research analysts have issued research reports on Embecta in the last year: Bank of America Co..
View the latest analyst ratings for EMBC.

What is the current price target for Embecta?

0 Wall Street analysts have set twelve-month price targets for Embecta in the last year. Their average twelve-month price target is $25.00, suggesting a possible downside of 4.6%.
View the latest price targets for EMBC.

What is the current consensus analyst rating for Embecta?

Embecta currently has 1 sell rating from Wall Street analysts. The stock has a consensus analyst rating of "Sell." A "sell" rating indicates that analysts believe EMBC will underperform the market and that investors should sell shares of Embecta.
View the latest ratings for EMBC.

How do I contact Embecta's investor relations team?

The company's listed phone number is 201-847-6880. The official website for Embecta is www.embecta.com. Learn More about contacing Embecta investor relations.